Passfail.com News: Analyst Moves: AGN, BIIB

Описание: Allergan (AGN) had its price target increased by Citigroup (C) to $124 as the company's core business continues to grow at double digit rates.

Shares are lower by about 2.4 percent.

Biogen Idec (BIIB) had its numbers increased by Jefferies (JEF) as the acquisitions of Tysabri rights should add to the bottom line. A buy rating was issued with a price target of $210.

Shares are lower by about one percent.

This is Sayoko Murase for Passfail.com, taking you behind the ticker.

For Passfail.com, Behind The Ticker (TM)
Pass Fail News